obesity drug news today glp-1 oct 27 2025 The Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Drugs glp-1 obesity drug news october

The retail pharmacies segment led the GLP-1 targeted peptide weight loss drugs market in 2024 due to their widespread accessibility and convenience for patients

This selective GH-releasing peptide garners attention for its promising role in facilitating fat loss, particularly in women

Owing to the enzymes being secreted locally, the expression levels of LOXs and their subsequent activity have been correlated with the modulation and transformation of the cells

20% of routines created by our community use it in both the morning and evening

Protein carbonyls (marker of oxidative protein damage) were measured using the Protein Carbonyl Colorimetric assay (Cayman Chemical Company, Ann Arbor, MI, USA)

Kidney function markers stayed stable or improved